🇺🇸 FDA
Patent

US 6248791

Stimulating the differentiation of preadipocytic cells and therapies based thereon

expired A61KA61K31/195A61K31/20

Quick answer

US patent 6248791 (Stimulating the differentiation of preadipocytic cells and therapies based thereon) held by Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma
Grant date
Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/195, A61K31/20, A61P, A61P3/02